OpenFilings

Cidara Therapeutics, Inc.

Form10-K

Report Period2022-12-31

Date Filed2023-03-23

Time Filed07:00:50

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

CIDARA THERAPEUTICS, INC. 2022 FORM 10-K
AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002
CLOUDBREAK GRAPHIC
Filing on SEC Edgar